DRD3 and Parkinson disease: Of note, equivalent to the situation of inflammatory colitis, we have shown that DRD3-deficiency in CD4+ T-cells results in a complete attenuation of MPTP-induced neurodegeneration and the treatment of wild-type mice with a selective DRD3-antagonist significantly reduces the development of PD in two different animal models (46, 103).